Controlling cytokine signaling by constitutive inhibitors

被引:96
作者
Rakesh, K
Agrawal, DK [1 ]
机构
[1] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA
[2] Creighton Univ, Sch Med, Dept Internal Med, Omaha, NE 68178 USA
[3] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA
关键词
cytokines; JAK/STAT signalling; SOCS; SHP; PIAS; inhibitors of signaling;
D O I
10.1016/j.bcp.2005.04.042
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytokines are secreted proteins that regulate diverse biological functions by binding to receptors at the cell surface to activate complex signal transduction pathways including the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway. Stringent mechanisms of signal attenuation are essential for ensuring an appropriate, controlled cellular response. Three families of proteins, the SH2-containing phosphatases (SHP), the protein inhibitors of activated STATs (PIAS), and the suppressors of cytokine signaling (SOCS), inhibit specific and distinct aspects of cytokine signal transduction. The analysis of mice lacking genes for members of the SHP has shed much light on the roles of these proteins in vivo. In recent in vitro studies, the protein modifiers ubiquitin and small ubiquitin-like modifier (SUMO) have emerged as key players in the strategies employed by SOCS and PIAS to repress signaling. This review throws light on the mechanisms of action of these regulators as being evolved by the latest researches. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:649 / 657
页数:9
相关论文
共 50 条
[1]   PIASx is a transcriptional co-repressor of signal transducer and activator of transcription 4 [J].
Arora, T ;
Liu, B ;
He, HC ;
Kim, J ;
Murphy, TL ;
Murphy, KM ;
Modlin, RL ;
Shuai, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (24) :21327-21330
[2]   Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNα [J].
Brender, C ;
Lovato, P ;
Sommer, VH ;
Woetmann, A ;
Mathiesen, AM ;
Geisler, C ;
Wasik, M ;
Odum, N .
LEUKEMIA, 2005, 19 (02) :209-213
[3]   SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation [J].
Chemnitz, JM ;
Parry, RV ;
Nichols, KE ;
June, CH ;
Riley, JL .
JOURNAL OF IMMUNOLOGY, 2004, 173 (02) :945-954
[4]   Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis [J].
Chen, BB ;
Bronson, RT ;
Klaman, LD ;
Hampton, TG ;
Wang, JF ;
Green, PJ ;
Magnuson, T ;
Douglas, PS ;
Morgan, JP ;
Neel, BG .
NATURE GENETICS, 2000, 24 (03) :296-299
[5]   SOCS: role in inflammation, allergy and homeostasis [J].
Elliott, J ;
Johnston, JA .
TRENDS IN IMMUNOLOGY, 2004, 25 (08) :434-440
[6]   Shp-2 tyrosine phosphatase: Signaling one cell or many [J].
Feng, GS .
EXPERIMENTAL CELL RESEARCH, 1999, 253 (01) :47-54
[7]   In vivo activation of the interleukin-6 receptor/gp130 signaling pathway in pituitary corticotropes of lipopolysaccharide-treated rats [J].
Gautron, L ;
Lafon, P ;
Tramu, G ;
Layé, S .
NEUROENDOCRINOLOGY, 2003, 77 (01) :32-43
[8]   PIASy-mediated repression of the androgen receptor is independent of sumoylation [J].
Gross, M ;
Yang, R ;
Top, I ;
Gasper, C ;
Shuai, K .
ONCOGENE, 2004, 23 (17) :3059-3066
[9]   Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity [J].
Hanada, T ;
Yoshida, H ;
Kato, S ;
Tanaka, K ;
Masutani, K ;
Tsukada, J ;
Nomura, Y ;
Mimata, H ;
Kubo, M ;
Yoshimura, A .
IMMUNITY, 2003, 19 (03) :437-450
[10]   Cloning and characterization of a functional promoter of the human SOCS-3 gene [J].
He, B ;
Hou, L ;
Uematsu, K ;
Matsangou, M ;
Xu, ZD ;
He, M ;
McCormick, F ;
Jablons, DM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 301 (02) :386-391